eComparison of oral buprenorphine/naloxone, depot buprenorphine and methadone for patients released from custodial settings with opioid use disorder

被引：0

作者：

Shi, Avelyn ^{[1
]}

Naz, Rokshar ^{[1
]}

Hanby, Matthew F. ^{[1
]}

McKenzie, Cameron R. L. ^{[1
]}

Moe, Syed ^{[1
]}

Dunlop, Adrian J. ^{[1
,2
,3
,4
]}

机构：

[1] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia

[2] Hunter New England Local Hlth Dist, Drug & Alcohol Clin Serv, Newcastle, NSW, Australia

[3] Hunter Med Res Inst, Healthcare Transformat Res Program, Newcastle, NSW, Australia

[4] Drug & Alcohol Clin Res & Improvement Network, Sydney, NSW, Australia

来源：

DRUG AND ALCOHOL REVIEW | 2023年 / 42卷

关键词：

D O I：

暂无

中图分类号：

R194 [卫生标准、卫生检查、医药管理];

学科分类号：

摘要：

252

引用

页码：S164 / S164

页数：1

共 50 条

[41] Primary care management of opioid use disorders Abstinence, methadone, or buprenorphine-naloxone? [J].

Srivastava, Anita ;

Kahan, Meldon ;

Nader, Maya .

CANADIAN FAMILY PHYSICIAN, 2017, 63 (03) :200-205

[42] Opioid Maintenance Therapy: A Review of Methadone, Buprenorphine, and Naltrexone Treatments for Opioid Use Disorder [J].

Fipps, David C. ;

Oesterle, Tyler S. ;

Kolla, Bhanu P. .

SEMINARS IN NEUROLOGY, 2024, 44 (04) :441-451

[43] Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences [J].

Neale, Joanne ;

Tompkins, Charlotte N. E. ;

Strang, John .

DRUG AND ALCOHOL REVIEW, 2019, 38 (05) :510-518

[44] Predicting buprenorphine adherence among patients with opioid use disorder in primary care settings [J].

Hooker, Stephanie A. ;

Starkey, Colleen ;

Bart, Gavin ;

Rossom, Rebecca C. ;

Kane, Sheryl ;

Olson, Anthony W. .

BMC PRIMARY CARE, 2024, 25 (01)

[45] Monthly buprenorphine depot injection (SUBLOCADE®) for opioid use disorder during pregnancy [J].

Ramage, Melinda ;

Bishop, Becky ;

Mangano, Vikki ;

Mankabady, Baher .

AMERICAN JOURNAL ON ADDICTIONS, 2025,

[46] Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder [J].

Shcherbakova, Natalia ;

Tereso, Gary ;

Spain, Jacqueline ;

Roose, Robert J. .

ANNALS OF PHARMACOTHERAPY, 2018, 52 (05) :405-414

[47] The OPTIMA study, buprenorphine/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale [J].

Socias, M. Eugenia ;

Ahamad, Keith ;

Le Foll, Bernard ;

Lim, Ron ;

Bruneau, Julie ;

Fischer, Benedikt ;

Wild, T. Cameron ;

Wood, Evan ;

Jutras-Aswad, Didier .

CONTEMPORARY CLINICAL TRIALS, 2018, 69 :21-27

[48] Buprenorphine and Methadone Treatment is Associated With Less Heart Failure Hospitalizations in Patients With Opioid Use Disorder [J].

Tysarowski, Maciej ;

Kazmi, Maryam ;

Barai, Rakhee ;

Efobi, Ranye ;

Matassa, Daniel ;

Gordon, Emily .

CIRCULATION, 2020, 142

[49] Integrating Buprenorphine for Opioid Use Disorder into Rural, Primary Care Settings [J].

Wyse, Jessica J. ;

Eckhardt, Alison ;

Newell, Summer ;

Gordon, Adam J. ;

Morasco, Benjamin J. ;

Carlson, Kathleen ;

Korthuis, P. Todd ;

Ono, Sarah S. ;

Lovejoy, Travis I. .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2024, 39 (12) :2142-2149

[50] Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use Disorder [J].

Shulman, Matisyahu ;

Luo, Sean X. ;

Campbell, Aimee N. C. ;

Scodes, Jennifer ;

Pavlicova, Martina ;

Broffman, Andi ;

Saxon, Andrew J. ;

Nunes, Edward, V .

JOURNAL OF ADDICTION MEDICINE, 2020, 14 (05) :E188-E194

← 1 2 3 4 5 →